When a virtue becomes a problem. The new oral anticoagulants.
Díaz-Cremades
J M
JM
Ruano
J A
JA
Fernández-Fuertes
F
F
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000627:therapeutic use; D000069604:Dabigatran; D004358:Drug Therapy / Q000639:trends; D006801:Humans; D055118:Medication Adherence; D012306:Risk; D014812:Vitamin K / Q000037:antagonists & inhibitors; D014859:Warfarin / Q000009:adverse effects; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014812:Vitamin K; D014859:Warfarin; D000069604:Dabigatran